- Home
- ARWR vs WBS Comparison
ARWR vs WBS Comparison
Compare ARWR & WBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARWR | WBS |
|---|---|---|
| Founded | 2003 | 1935 |
| Country | United States | United States |
| Employees | N/A | 4601 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 11.8B |
| IPO Year | 2009 | N/A |
Fundamental Metrics
Financial Performance| Metric | ARWR | WBS |
|---|---|---|
| Price | $73.08 | $72.59 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 15 |
| Target Price | ★ $83.40 | $73.64 |
| AVG Volume (30 Days) | 1.4M | ★ 2.8M |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 2.23% |
| EPS Growth | ★ 99.80 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $16,142,321.00 | N/A |
| Revenue This Year | N/A | $5.32 |
| Revenue Next Year | N/A | $5.89 |
| P/E Ratio | ★ N/A | $12.28 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $14.30 | $50.66 |
| 52 Week High | $82.26 | $74.00 |
Technical Indicators
Market Signals| Indicator | ARWR | WBS |
|---|---|---|
| Relative Strength Index (RSI) | 47.50 | 53.01 |
| Support Level | $70.19 | $71.13 |
| Resistance Level | $77.39 | $73.72 |
| Average True Range (ATR) | 3.54 | 0.67 |
| MACD | -0.75 | -0.04 |
| Stochastic Oscillator | 34.34 | 51.59 |
Price Performance
Historical ComparisonAbout ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.
About WBS Webster Financial Corporation
Webster Financial Corp is a full-service provider of financial services, offering commercial and consumer banking, mortgages, and investment advisory along with trust and wealth management services in Connecticut, New York, Rhode Island, Massachusetts, and Pennsylvania. The company's segment includes Commercial Banking, HSA Bank, and Consumer Banking. It generates maximum revenue from the Commercial Banking segment.